secwatch.observer — SEC 8-K summary
======================================

Issuer:     Climb Bio, Inc. (CLYM)
CIK:        0001768446
Form:       8-K
Filed at:   2024-10-02T23:59:59+00:00
Accession:  0001193125-24-231167
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eliem Therapeutics renames to Climb Bio, ticker changes to CLYM on Nasdaq
-------------------------------------------------------------------------

- Name change from Eliem Therapeutics, Inc. to Climb Bio, Inc. effective October 2, 2024.
- New trading symbol CLYM on Nasdaq Global Market starts October 3, 2024.
- CUSIP number for common stock remains unchanged; stockholder rights unaffected.
- Certificate of incorporation amended solely for name; bylaws conformed to new name.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768446/000119312524231167/0001193125-24-231167-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768446/000119312524231167/d888487d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-231167

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer